-2.4 C
New York
Tuesday, February 24, 2026

The FDA Just Approved an RSV Vaccine — and It Isn’t From Moderna or Pfizer

RSV could be the next big battleground for big pharma — but it could soon become crowded. Moderna (MRNA -2.58%) and Pfizer (PFE -2.34%) are two …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

149,490FansLike
396,312FollowersFollow
2,650SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x